Lung cancer incidence rates in the world from the Cancer Incidence in Five Continents XI

Lung cancer incidence rates in the world from the Cancer Incidence in Five Continents XI In order to make a comparison of recent cancer incidence rates between Japan and other countries, we abstracted the age-standardized incidence rates (ASRs) by three age categories (0–59, 60–74, 75+) from the Cancer Incidence in Five Continents Vol. XI (CI5) (1). International Agency for Research on Cancer provides the CI5 databases on the incidence of cancer recorded by cancer registries (regional and national) worldwide. We extracted ASRs from the following cancer registries; the United States of America, Beijing in China, Mumbai in India, Hiroshima and Osaka in Japan, the Republic Korea, Gironde in France, Hamburg in Germany, the United Kingdom and Australia from the CI5-XI database. The period of years at cancer diagnosis were from 2008 to 2012. Figure 1 shows the ASRs for lung cancer coded as C33-34 (ICD10) of males. The ASRs of males who were over 75 year old in Japan (Osaka and Hiroshima), and the Republic of Korea were higher than those in other countries or regions, while the ASRs of males in aged 0-59 and 60-74 groups were almost similar among the selected countries or regions except those in India (Mumbai). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2 shows the ASRs for lung cancer coded as C33-34 (ICD10) of females. The ASRs of females who were over 75 year old in the United States of America, the United Kingdom, and China (Beijing) were higher (about 300 per 100,000), while those in Japan (Osaka and Hiroshima), Australia, the Republic of Korea, and Germany (Hamburg) were slightly lower (about 200 per 100,000). The ASRs of females in aged 60–74 group in the United States of America, the United Kingdom, and Germany (Hamburg) were slightly higher than those in other countries or regions. Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Overall the ASRs for lung cancer of males, in particular in over 75 year old group, were higher than those of females in each country or region. This differences in Japan (Osaka and Hiroshima) and the Republic Korea were larger than other countries or regions. Note: Data were downloaded from the Global Cancer Observatory (GCO), which was an interactive web-based platform presenting global cancer statistics (https://gco.iarc.fr/). Responsibility for this presentation and interpretation lies with the authors of this article. Reference 1 Bray F, Colombet M, Mery L, et al.  , editors. Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr, accessed [2018/1/10]. © The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Japanese Journal of Clinical Oncology Oxford University Press

Lung cancer incidence rates in the world from the Cancer Incidence in Five Continents XI

Loading next page...
 
/lp/ou_press/lung-cancer-incidence-rates-in-the-world-from-the-cancer-incidence-in-JYX0bQir7F
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
ISSN
0368-2811
eISSN
1465-3621
D.O.I.
10.1093/jjco/hyy021
Publisher site
See Article on Publisher Site

Abstract

In order to make a comparison of recent cancer incidence rates between Japan and other countries, we abstracted the age-standardized incidence rates (ASRs) by three age categories (0–59, 60–74, 75+) from the Cancer Incidence in Five Continents Vol. XI (CI5) (1). International Agency for Research on Cancer provides the CI5 databases on the incidence of cancer recorded by cancer registries (regional and national) worldwide. We extracted ASRs from the following cancer registries; the United States of America, Beijing in China, Mumbai in India, Hiroshima and Osaka in Japan, the Republic Korea, Gironde in France, Hamburg in Germany, the United Kingdom and Australia from the CI5-XI database. The period of years at cancer diagnosis were from 2008 to 2012. Figure 1 shows the ASRs for lung cancer coded as C33-34 (ICD10) of males. The ASRs of males who were over 75 year old in Japan (Osaka and Hiroshima), and the Republic of Korea were higher than those in other countries or regions, while the ASRs of males in aged 0-59 and 60-74 groups were almost similar among the selected countries or regions except those in India (Mumbai). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 1. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2 shows the ASRs for lung cancer coded as C33-34 (ICD10) of females. The ASRs of females who were over 75 year old in the United States of America, the United Kingdom, and China (Beijing) were higher (about 300 per 100,000), while those in Japan (Osaka and Hiroshima), Australia, the Republic of Korea, and Germany (Hamburg) were slightly lower (about 200 per 100,000). The ASRs of females in aged 60–74 group in the United States of America, the United Kingdom, and Germany (Hamburg) were slightly higher than those in other countries or regions. Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Figure 2. View largeDownload slide Age-standardized Incidence rates for males in lung cancer (per 100,000). Overall the ASRs for lung cancer of males, in particular in over 75 year old group, were higher than those of females in each country or region. This differences in Japan (Osaka and Hiroshima) and the Republic Korea were larger than other countries or regions. Note: Data were downloaded from the Global Cancer Observatory (GCO), which was an interactive web-based platform presenting global cancer statistics (https://gco.iarc.fr/). Responsibility for this presentation and interpretation lies with the authors of this article. Reference 1 Bray F, Colombet M, Mery L, et al.  , editors. Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr, accessed [2018/1/10]. © The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Journal

Japanese Journal of Clinical OncologyOxford University Press

Published: Mar 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial